Parmax Pharma fundamental analysis
PARMAX
32.6
0.40 (-1.21%)Last updated on 7 Nov, 2025 | 14:50 IST
BUYSELL
The current prices are delayed, login to your account for live prices
LoginParmax Pharma Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
36.99
Sector P/B
3.63
Sec. Div. Yield
0.56
- Parmax Pharma Fundamentals is currently trading with a P/E Ratio of 0, compared to the sector average of 36.99. Its P/B Ratio stands at 0, while the sector’s is 3.63. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.56%.
Parmax Pharma Score Card
Price
Attractive
Growth
Poor
Quality
Poor
Management
Poor
- On its scorecard, Parmax Pharma reflects: Price – Attractive, Growth – Poor, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.